Oxygenator performance and artificial-native lung interaction.

Area of Science:

• Critical Care Medicine
• Biomedical Engineering
• Cardiopulmonary Physiology

Background:

• Extracorporeal membrane oxygenation (ECMO) supports gas exchange, partitioning oxygen (O2) and carbon dioxide (CO2) between the native lung (NL) and the membrane lung (ML).
• ML function can decline due to aging, pseudomembranous deposits causing shunt effects, and clot formation leading to dead space effects, impacting O2 transfer (V'O2ML) and CO2 removal (V'CO2ML).

Purpose of the Study:

• To evaluate the clinical impact of a real-time ECMO circuit monitoring system.
• To assess the utility of monitoring shunt and dead space effects for recognizing ML function decline and guiding ECMO management.

Main Methods:

• Utilized a real-time ECMO circuit monitoring system integrated with standard measurements and samplings.
• Calculated ML gas exchange efficiency, V'O2ML, and V'CO2ML.
• Monitored for shunt and dead space effects indicative of ML dysfunction.

Main Results:

• Real-time monitoring provides timely and precise analysis of ECMO functioning.
• Monitoring shunt and dead space effects aids in recognizing ML function decline.
• Integration of real-time data improves ECMO safety and management, including ML replacement timing and weaning procedures.

Conclusions:

• A real-time ECMO circuit monitoring system significantly enhances safety and clinical decision-making.
• Accurate analysis of ML and NL status is fundamental for understanding ECMO-patient interaction.
• Real-time monitoring offers critical information for optimizing ECMO therapy and patient outcomes.